News
5d
Medical Device Network on MSNNovocure’s device for metastatic NSCLC treatment gains CE MarkThe data from the Phase III LUNAR trial, which assessed the device’s treatment efficacy and safety, supported the approval.
Approved for CE credit through HSPA and CBSPD, this course is ideal for Sterile Processing Technicians, Supervisors, and Healthcare Safety Officers seeking to elevate their understanding of ...
Optune Lua is now approved for use concurrently with immune checkpoint inhibitors or docetaxel in adult patients with metastatic NSCLC who have progressed on or after a platinum-based regimen CE ...
Vivasure Medical announced today that it received CE mark approval for its PerQseal Elite vascular closure system.
Edwards Lifesciences announced today that it received CE mark approval for its Sapien M3 mitral valve replacement system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results